Visible Genomics

Preventing Vision Loss with a Simple Genetic Test

Print
Claim My Business
Form C
View on StartEngine
Min Investment
$493
Location
Oakbrook Terrace, IL
Expected Close Date
November 05, 2024
Target Raise
$15.00K-$1.23M
Security Price
$9.48
Website
visiblegenomics.com
Number of Employees
2
Cash
$3,808
Revenue
$31,768
Short Term Debt
$2,004,044
Cost of Goods
$26,490
Long Term Debt
$0
Net Income
$-600,827

Company Description

Visible Genomics is an early-growth stage genetics-based testing and risk assessment company with a focus on severe ocular diseases. Our signature product, AMDiGuard™, is a simple cheek swab test that uses advanced DNA analysis and proprietary algorithms to assess risk and analyze progression of age-related macular degeneration (AMD), empowering medical professionals and patients to potentially delay or prevent disease onset.
Amount Raised : $16,209
Reveal the Score by Voting
＿
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
ⓘ
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
ⓘ
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
ⓘ
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
ⓘ
The value of the company compared to similar companies raising money from investors.
Valuation

Research Reports

No reports have been submitted

Become a Reporter
Read Our Research Disclaimer

0 Comments

Post Comment